| A Study on the Tolerability and Early Efficacy of hLF1-11 in Patients With Bacteremia Due to S. Epidermidis (NCT00509847) | AM-Pharma | 2009-02-01 |
| Validation Study of Combined Positron Emission Tomography/Computer Tomography to Diagnose Infection and Inflammation (NCT00835783) | Odense University Hospital | 2008-11-01 |
| The Impact of Material on Microbiota in Association With Tongue and Lip Piercing (NCT01039259) | Medical University Innsbruck | 2008-08-01 |
| Procalcitonin Level and Kinetics in Children With Bacterial Infections (NCT00714402) | Shaare Zedek Medical Center | 2008-08-01 |
| MicroPhage S. Aureus / MSSA / MRSA Blood Culture Beta Trial (NCT00814151) | MicroPhage, Inc. | 2008-07-01 |
| Optimizing Dosing of Colistin for Infections Resistant to All Other Antibiotics, Approved NIH Protocol Dated 12.06.07(DMID Protocol #07-0036) (NCT00235690) | University of Pittsburgh | 2008-06-01 |
| Taurolidine Lock Solution in the Prevention of Catheter Related Bacteremia (NCT00735813) | Aarhus University Hospital | 2008-04-01 |
| UGIST: Ultrasound Guided Internal Jugular Short-Term Central Venous Catheters Tunneling (NCT00639197) | Hamilton Health Sciences Corporation | 2008-03-01 |
| Efficacy, Immunogenicity, and Safety of a Single Dose of V710 in Adult Patients Scheduled for Cardiothoracic Surgery (V710-003 AM2) (NCT00518687) | Merck Sharp & Dohme LLC | 2007-12-01 |
| Piperacillin/Tazobactam for Bacteremia With Organisms Producing Chromosomally-Encoded AmpC Beta-Lactamase (NCT00414193) | University of Pittsburgh | 2007-02-01 |
| Clinical Impact of Fluoroquinolone Resistance in Bacteremia Caused by Gram-Negative Bacilli of Urinary Tract Origin (NCT00414362) | University of Pittsburgh | 2007-02-01 |
| Dressing: Frequency of Change and Evaluation of an Antiseptic-Impregnated Catheter Dressing in ICU Patients (NCT00417235) | University Hospital, Grenoble | 2007-01-01 |
| Impact of Procalcitonin on the Management of Children Aged 1 to 36 Month Presenting With a Fever Without a Source (NCT00692848) | St. Justine's Hospital | 2006-11-01 |
| Steady State Serum and Epithelial Lining Fluid (ELF) Antibiotics Concentrations Under Continous Infusion (NCT00435305) | University Hospital Tuebingen | 2006-11-01 |
| Moxifloxacin in the Prevention of Bacteremia After High-dose Chemotherapy and Transplantation of Peripheral Stem Cells (NCT00398411) | University of Cologne | 2006-10-01 |
| Infections Caused by ESbL-Producing Enterobacteriaceae in Italy (NCT00404625) | University of Siena | 2006-10-01 |
| Efficacy of Cefepime Continuous Infusion Versus an Intermittent Dosing Regimen (NCT00609375) | Javeriana University | 2006-09-01 |
| Colombia Epidemiologic Surveillance Study (NCT00428051) | Pfizer | 2006-09-01 |
| Concentrated Citrate Locking to Reduce the Incidence of CVC-related Complications in Hematological Patients (NCT01820962) | Maastricht University Medical Center | 2006-07-01 |
| The Role of Synbiotics in Reducing Post-Operative Infections in Patients Undergoing Cardiac Surgery: A Pilot Study (NCT00164099) | Beth Israel Medical Center | 2005-11-01 |
| Lebanese Interhospital Pneumococcal Surveillance Program (NCT00901602) | American University of Beirut Medical Center | 2005-10-01 |
| Pharmacodynamic Parameters of Two Different Doses of Cefepime (NCT00177736) | University of Pittsburgh | 2005-09-01 |
| Linezolid in the Treatment of Hemodialysis Patients With Catheter-Related Gram-Positive Bloodstream Infections (NCT00108433) | Pfizer | 2005-09-01 |
| Skin Cleansing With Chlorhexidine to Decrease Hospital Acquired Infections (NCT00130221) | Cook County Health | 2005-06-01 |
| Virulence Determinants in S Aureus Bacteremia (NCT00319826) | Duke University | 2004-03-01 |
| Prophylactic Antimicrobial Catheter Lock (NCT00571259) | Satellite Healthcare | 2003-09-01 |
| Bacteria Entering the Blood Stream From Tooth Extractions and Tooth Brushing (NCT00454285) | Wake Forest University Health Sciences | 2003-01-01 |
| Prevention of Catheter-Associated Infection With the Skin Disinfectant Octenidine Dihydrochloride (NCT00515151) | University Hospital Freiburg | 2002-05-01 |
| Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters Due to Gram Positive Bacteria (NCT00037050) | Pfizer | 2002-04-01 |
| Daptomycin in the Treatment of Subjects With Infective Endocarditis or Bacteremia Due to S. Aureus (NCT00093067) | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2002-03-01 |
| Clinical Outcomes and Cost of Gram Negative Bacteremia (NCT02599220) | Duke University | 2002-01-01 |
| Safety and Efficacy of Dalbavancin Versus Vancomycin in the Treatment of Catheter-Related Bloodstream Infections (NCT00057369) | Vicuron Pharmaceuticals | 2001-02-01 |
| Safety and Efficacy of MBI 226 for the Prevention of Central Venous Catheter-Related Bloodstream Infections (NCT00027248) | BioWest Therapeutics Inc | 2000-09-01 |
| Combination Therapy With Fluoroquinolone in Staphylococcus Aureus Bacteremia (NCT00548002) | University of Helsinki | 1999-01-01 |
| Impact of Continuous Venovenous Haemofiltration on Organ Failure During the Early Phase of Severe Sepsis (NCT00406198) | Hopital Lariboisière | 1997-03-01 |
| Prevention of Bacteremia Induced by Debridement of Pressure Ulcer (NCT00269100) | Herzog Hospital | |
| Ceftobiprole in the Treatment of Hospitalized Patients With Staphylococcus Aureus Bacteremia (NCT00505258) | Basilea Pharmaceutica | |
| Personalized Phage Treatment in Covid-19 Patients With Bacterial Co-Infections Microbials for Pneumonia or Bacteremia/Septicemia (NCT04636554) | Adaptive Phage Therapeutics, Inc. | |